Daniel T Johnson
Overview
Explore the profile of Daniel T Johnson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eerdekens R, Gebremedhin P, Johnson D, Kirkeeide R, Howe G, Howe G, et al.
Am J Physiol Heart Circ Physiol
. 2025 Jan;
328(2):H377-H385.
PMID: 39812771
An increasing number of procedures over the past two decades for aortic stenosis (AS) reflects the combination of an aging population and less invasive transcatheter options. As a result, the...
2.
Johnson D, Svanerud J, Ahn J, Bezerra H, Collison D, van t Veer M, et al.
Cardiovasc Revasc Med
. 2022 Aug;
46:98-105.
PMID: 35918253
Background/purpose: Matching phasic pressure tracings between a fluid-filled catheter and high-fidelity pressure wire has received limited attention, although each part contributes half of the information to clinical decisions. We aimed...
3.
Johnson D, Zhou J, Kroll A, Fang R, Yan M, Xiao C, et al.
Leukemia
. 2021 Nov;
36(4):994-1005.
PMID: 34845316
Cancer vaccines are promising treatments to prevent relapse after chemotherapy in acute myeloid leukemia (AML) patients, particularly for those who cannot tolerate intensive consolidation therapies. Here, we report the development...
4.
Davis A, Johnson D, Zheng D, Wang R, Jayne N, Liu M, et al.
Blood
. 2021 Sep;
139(3):424-438.
PMID: 34482400
Posttranscriptional regulation has emerged as a driver for leukemia development and an avenue for therapeutic targeting. Among posttranscriptional processes, alternative polyadenylation (APA) is globally dysregulated across cancer types. However, limited...
5.
Johnson D, Davis A, Zhou J, Ball E, Zhang D
Exp Hematol Oncol
. 2021 Feb;
10(1):8.
PMID: 33531067
Background: Acute myeloid leukemia (AML) with the t(8;21)(q22;q22) chromosomal translocation is among the most common subtypes of AML and produces the AML1-ETO (RUNX1-ETO, RUNX1-RUNX1T1) oncogenic fusion gene. AML1-ETO functions as...
6.
Zimmermann F, Mast T, Johnson N, Everts I, Hennigan B, Berry C, et al.
EuroIntervention
. 2020 Sep;
17(1):51-58.
PMID: 32863244
Background: It would be ideal for a non-hyperaemic index to predict fractional flow reserve (FFR) more accurately, given FFR's extensive validation in a multitude of clinical settings. Aims: The aim...
7.
Johnson D, Fournier S, Kirkeeide R, De Bruyne B, Gould K, Johnson N
Catheter Cardiovasc Interv
. 2020 Feb;
96(3):E268-E277.
PMID: 32077561
Objectives: We sought to develop an automatic method for correcting common errors in phasic pressure tracings for physiology-guided interventions on coronary and valvular stenosis. Background: Effective coronary and valvular interventions...
8.
Stoner S, Yan M, Liu K, Arimoto K, Shima T, Wang H, et al.
Blood
. 2019 Aug;
134(20):1730-1744.
PMID: 31434702
Heterozygous deletions within chromosome 20q, or del(20q), are frequent cytogenetic abnormalities detected in hematologic malignancies. To date, identification of genes in the del(20q) common deleted region that contribute to disease...
9.
He Y, Johnson D, Yang J, Wu H, You S, Yoon J, et al.
Oncogene
. 2019 Jul;
38(38):6507-6520.
PMID: 31358900
Recent genome analysis of human prostate cancers demonstrated that both AR gene amplification and TP53 mutation are among the most frequently observed alterations in advanced prostate cancer. However, the biological...
10.
Mi J, Hooker E, Balog S, Zeng H, Johnson D, He Y, et al.
J Biol Chem
. 2018 Nov;
293(52):20123-20136.
PMID: 30401749
Emerging evidence has shown that the hepatocyte growth factor (HGF) and its receptor, MET proto-oncogene, receptor tyrosine kinase (MET), promote cell proliferation, motility, morphogenesis, and angiogenesis. Whereas up-regulation of MET...